Document is current
Any future updates will be listed below
-
Authors
Charmsaz, Sara
Doherty, Ben
Cocchiglia, Sinéad
Varešlija, Damir
Marino, Attilio
Cosgrove, Nicola
Marques, Ricardo
Priedigkeit, Nolan
Purcell, Siobhan
Bane, Fiona
Bolger, Jarlath
Byrne, Christopher
O’Halloran, Philip J.
Brett, Francesca
Sheehan, Katherine
Brennan, Kieran
Hopkins, Ann M.
Keelan, Stephen
Jagust, Petra
Madden, Stephen
Martinelli, Chiara
Battaglini, Matteo
Oesterreich, Steffi
Lee, Adrian V.
Ciofani, Gianni
Hill, Arnold D. K.
Young, Leonie S.
-
Funding
Funding for this research was provided by:
Science Foundation Ireland (15/BIAP/3185, 12/1A/1294)
Irish Cancer Society (CCRC13GAL)
Breast Cancer NOW (2018JulPR1094, 2019AugSF1310)
EU-FP7 (EU-FP7-IAPP)
- License Information
-
More Information
Article History
Received: 16 June 2020
Accepted: 2 October 2020
First Online: 19 November 2020
Ethics approval and consent to participate
: All patient clinical material was collected under the clinical trial NCT01840293 (ExternalRef removed, CTRIAL-IE 09/07) following ethical approval from Beaumont Hospital Medical Research Ethics Committee. All patients were fully consented onto the trial. All animal experiments were performed in accordance with the EU Directive 210/63/EU and were reviewed and approved by Research Ethics Committee, RCSI under licence from The Health Products Regulatory Authority. Experiments were undertaken in accordance with the Arrive Guidelines where appropriate.
: Not applicable.
: The authors declare that they have no competing interests. LY has previously had collaborative funding with Pfizer from Science Foundation Ireland.
